Castle Biosciences (NASDAQ:CSTL) Given New $40.00 Price Target at Scotiabank
Castle Biosciences (NASDAQ:CSTL – Get Free Report) had its target price reduced by Scotiabank from $44.00 to $40.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “sector outperform” rating on the stock. Scotiabank’s price objective indicates a potential upside of 151.73% from the stock’s previous close. Other analysts have also […]
Castle Biosciences (NASDAQ:CSTL – Get Free Report) had its target price reduced by Scotiabank from $44.00 to $40.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has a “sector outperform” rating on the stock. Scotiabank’s price objective indicates a potential upside of 151.73% from the stock’s previous close. Other analysts have also […]
